Phase I/II trial of Autologous Platelet Integrated Concentration (APIC) cell-free system for the rapid preparation of concentrated protease inhibitor alpha-2-macroglobulin (A2M) for the treatment of mild to moderate osteoarthritis of the knee
Latest Information Update: 25 May 2015
At a glance
- Drugs Alpha 2-macroglobulin (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
Most Recent Events
- 25 May 2015 New trial record